Ascentage Pharma Group In...

NASDAQ: AAPG · Real-Time Price · USD
46.61
0.21 (0.46%)
At close: Aug 20, 2025, 9:40 AM

Ascentage Pharma International Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
980.65M 221.98M 209.71M 4.33M
Cost of Revenue
29.09M 30.54M 22M 3.33M
Gross Profit
951.57M 191.44M 187.71M 24.58M
Operating Income
-369.73M -872.64M -849.81M -869.84M
Interest Income
37.84M 32.41M 9.73M 7.11M
Pretax Income
-395.25M -932.86M -887.17M -832.25M
Net Income
-405.43M -925.64M -882.92M -782.42M
Selling & General & Admin
383.12M 376.46M 328.02M 191.26M
Research & Development
947.25M 706.97M 743.1M 766.49M
Other Expenses
-9.07M -19.36M -33.6M -63.34M
Operating Expenses
1.32B 1.06B 1.04B 894.42M
Interest Expense
64.45M 96.06M 52.78M 16.73M
Selling & Marketing Expenses
196M 195.39M 157.42M 47.75M
Cost & Expenses
1.35B 1.09B 1.06B 897.75M
Income Tax Expense
10.43M -7.15M -4.25M -49.83M
Shares Outstanding (Basic)
75.52M 70.57M 65.92M 63.65M
Shares Outstanding (Diluted)
75.52M 70.57M 65.92M 63.65M
EPS (Basic)
-0.75 -13.12 -13.4 -12.28
EPS (Diluted)
-0.75 -13.12 -13.4 -12.28
EBITDA
-237.63M -743.61M -771.47M -787.19M
EBIT
-330.8M -836.8M -834.39M -815.52M
Depreciation & Amortization
93.17M 93.19M 9.13M 4.39M